Related Experiment Video
Updated: Jun 4, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Systemic hypertension in adults with congenital heart diseases
Jolanda Sabatino1,2, Martina Avesani1,2, Domenico Sirico1,2
1Department of Women's and Children's Health, University of Padua, Padua, Italy.
Insights
Hypertension in adults with congenital heart disease (ACHD) is understudied. This review examines risk factors, consequences, and treatments for hypertension in ACHD patients to improve long-term outcomes.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease
- Hypertension Research
Background:
- Systemic hypertension (HTN) effects are well-documented in adults without congenital heart disease.
- Limited data exists on HTN predisposing factors, prevalence, consequences, and treatment in adults with congenital heart disease (ACHD).
Purpose of the Study:
- To investigate the risk factors, effects, and treatments of HTN in ACHD patients.
- To highlight the need for meticulous follow-up and tailored strategies for HTN management in this population.
Main Methods:
- This review synthesizes current literature on HTN in ACHD.
- It explores underlying cardiac disease, surgical history, and metabolic syndrome as contributing factors.
Main Results:
- Several mechanisms contribute to HTN in ACHD, including underlying cardiac conditions, post-surgical sequelae, and metabolic syndrome.
- A significant knowledge gap exists regarding HTN in ACHD.
Conclusions:
- HTN in ACHD requires dedicated investigation and management strategies.
- Meticulous follow-up and individualized treatment are crucial for mitigating long-term HTN effects in ACHD patients.
Abstract:
Long-term effects of systemic hypertension (HTN) and HTN-mediated damages have been largely studied in non-congenital adult populations. By contrast, robust data about the predisposing factors, prevalence, consequences, and treatment of HTN in adults with congenital heart diseases (ACHD) is still scarce. Different mechanisms including the underlying cardiac disease, cardiac surgery and its consequences, the development of metabolic syndrome and secondary forms seem to play a role in HTN in ACHDs. To mitigate the potential long-term effects of HTN in this complex population, a meticulous follow-up is mandatory to identify patients who should receive treatment, and tailored strategies should be applied to obtain the best as possible result. Thus, this review will investigate risk factors, effects, and treatments of HTN in ACHD patients.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Measurement of Blood Pressure
Pathophysiology of Heart Failure
Blood Pressure

